These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6682203)

  • 1. Amitriptyline in Alzheimer's disease.
    Reding MJ; Young R; DiPonte P
    Neurology; 1983 Apr; 33(4):522-3. PubMed ID: 6682203
    [No Abstract]   [Full Text] [Related]  

  • 2. Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer's dementia.
    Nielsen RE; Lolk A; Valentin JB; Andersen K
    Acta Psychiatr Scand; 2016 Oct; 134(4):314-20. PubMed ID: 27357602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of the effects of antidementia agents.
    Siegfried KR
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():592A-593A. PubMed ID: 1498964
    [No Abstract]   [Full Text] [Related]  

  • 4. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 5. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine in dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition.
    Geldmacher DS; Waldman AJ; Doty L; Heilman KM
    J Clin Psychiatry; 1994 Apr; 55(4):161. PubMed ID: 8071261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of reminyl (galantamine) in the treatment of dementia].
    Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of pharmacological toxicity using serum anticholinergic activity in a patient with dementia.
    Hori K; Funaba Y; Konishi K; Moriyasu M; Hirata K; Oyamada R; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):508-10. PubMed ID: 16048459
    [No Abstract]   [Full Text] [Related]  

  • 10. Delusions in dementia: a review.
    Flint AJ
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):121-30. PubMed ID: 1687962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
    Rainer M; Kraxberger E; Haushofer M; Mucke HA; Jellinger KA
    J Neural Transm (Vienna); 2000; 107(12):1475-81. PubMed ID: 11459000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP; Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
    Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
    J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of psychiatric scales in patients with dementia of the Alzheimer type.
    Gottlieb GL; Gur RE; Gur RC
    Am J Psychiatry; 1988 Jul; 145(7):857-60. PubMed ID: 3381932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.
    Lyketsos CG; Corazzini K; Steele CD; Kraus MF
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):67-73. PubMed ID: 8845704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease.
    Taragano FE; Lyketsos CG; Mangone CA; Allegri RF; Comesaña-Diaz E
    Psychosomatics; 1997; 38(3):246-52. PubMed ID: 9136253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Test scores as indicators of treatment efficacy in dementia caused by Alzheimer's disease in clinical practice].
    Gavrilova SI; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):48-53. PubMed ID: 25726780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.